Newsroom

REDLANDS, Califórnia--(BUSINESS WIRE)--A Esri expandiu seu Programa de Mapas Comunitários, permitindo que dados sobre fechamento de vias sejam compartilhados com o Google Maps e o Waze. A solução Road Closures, na plataforma ArcGIS da Esri, foi lançada no ano passado como uma forma de os usuários compartilharem facilmente atualizações sobre fechamento de vias diretamente com os principais provedores de mapas, permitindo que eles atualizem seus mapas com essas informações importantes. A solução...

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), een leider op het gebied van innovatie in immuno-oncologie, heeft vandaag bekendgemaakt dat het een overeenkomst voor de aankoop van effecten heeft gesloten voor een onderhandse plaatsing met een bruto-opbrengst van ongeveer 85 miljoen dollar vooraf, vóór aftrek van de kosten van de onderhandse plaatsing, en tot 255 miljoen dollar extra bij volledige uitoefening van de aankoopwarrants. De financiering werd geleid door Commodore Capi...

MALVERN, Pa.--(BUSINESS WIRE)--Triple-I has been recognized with a Silver Award from the Bulldog PR Awards for its 2025 Georgia legal system abuse awareness campaign....

LOS ANGELES--(BUSINESS WIRE)--BE Investors Have Opportunity to Join Bloom Energy Corporation Fraud Investigation with the Schall Law Firm...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Charles Schwab Investment Management, Inc. (CSIM) in its capacity as investment advisor to clients. CSIM expressly disclaims beneficial ownership of the shares described in this form 8.3. (b) Owner or controller of interests and short positions...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Charles Schwab Investment Management, Inc. (CSIM) in its capacity as investment advisor to clients. CSIM expressly disclaims beneficial ownership of the shares described in this form 8.3. (b) Owner or controller of interests and short positions...

REDLANDS, Calif.--(BUSINESS WIRE)--Esri heeft zijn Community Maps Program uitgebreid, zodat gegevens over wegafsluitingen met Google Maps en Waze kunnen worden gedeeld. Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal, die als enige rechtsgeldig is....

AUSTIN, Texas--(BUSINESS WIRE)--UBS today announced that Samuel Duckett has joined the firm as a Financial Advisor in its Austin, Texas office. Samuel joins UBS’s Central Region, led by Jon Ramey, and will report to Market Executive Tommy Stacy and Market Director Jeff Bidstrup. Samuel joins UBS from Morgan Stanley, where he spent the past six years advising individuals and families on wealth management strategies. At UBS, he will partner with Financial Advisor Will Lawes, who joined the firm t...

REDLANDS, Calif.--(BUSINESS WIRE)--Esri a étendu son programme Community Maps, permettant ainsi le partage des données relatives aux fermetures de routes avec Google Maps et Waze. La solution « Road Closures », intégrée à la plateforme ArcGIS d’Esri, a été lancée l’année dernière afin de permettre aux utilisateurs de partager facilement les mises à jour concernant les fermetures de routes directement avec les principaux fournisseurs de services de cartographie grand public, afin que ceux-ci pui...

SINGAPORE & SAN DIEGO--(BUSINESS WIRE)--GemPharmatech, an international provider of in vivo efficacy testing and genetically engineered animal models, and Humlab Global, a Singapore-based developer of humanized mouse models and translational research solutions, today announced the signing of an agreement for the global distribution of existing and novel humanized strains. The rapid development of advanced therapeutics has increased the need for in vivo models that better predict drug efficacy a...